Keyphrases
C-Fos
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Cell Properties
100%
Cancer Stem-like
100%
Squamous Carcinoma Cells
36%
Overexpression
18%
Tumor Growth
18%
Epithelial-mesenchymal Transition
18%
Nanog
9%
Sex-determining Region Y-box 2 (SOX2)
9%
C-Myc
9%
Stem Cell Reprogramming
9%
Surgical Technique
9%
Chemoresistance
9%
Cancer Stem Cells
9%
Overexpressing
9%
Chemotherapy
9%
Therapeutic Approaches
9%
Squamous Cell Tumor
9%
Stemness
9%
Common Cancers
9%
Ectopic Expression
9%
Immunodeficient Mice
9%
Distant Recurrence
9%
Nude Mice
9%
Locoregional Recurrence
9%
Supportive Care
9%
Quality of Life Improvement
9%
Cyclin D1 (CCND1)
9%
Cell Markers
9%
Delivery Care
9%
Mechanistic Investigation
9%
Notch1
9%
Carcinoma Cell Lines
9%
Transition State
9%
Exogenous Expression
9%
Sphere Formation
9%
Subcutaneous Transplantation
9%
C-Fos Protein
9%
Sphere-forming Cells
9%
Immunology and Microbiology
Oncogene C Fos
100%
Squamous Cell
100%
Neck
100%
Squamous Cell Carcinoma Cell
27%
Epithelial Mesenchymal Transition
18%
Cancer Stem Cell
9%
Drug Resistance
9%
Upregulation
9%
Nude Mouse
9%
Ectopic Expression
9%
Cyclin D1
9%
Cell Marker
9%
Oncogene C Myc
9%
Head and Neck Squamous Cell Carcinoma Cell Line
9%
Nuclear Reprogramming
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Head and Neck Squamous Cell Carcinoma
100%
Tumor Growth
18%
Recurrent Disease
18%
Chemotherapy
9%
Drug Resistance
9%
Nude Mouse
9%
Cyclin D1
9%
Cell Marker
9%
Biochemistry, Genetics and Molecular Biology
C-Fos
100%
Tumor Progression
18%
Mesenchymal-Epithelial Transition
18%
Upregulation
9%
Nanog
9%
Nuclear Reprogramming
9%
Oncogene C Myc
9%
Drug Resistance
9%
Ectopic Expression
9%
Cell Marker
9%
Cancer Stem Cell
9%
Nude Mouse
9%
Cyclin D1
9%